NeuroFrontiers cover art

All Episodes

NeuroFrontiers — 191 episodes

#
Title
1

Can We Delay Alzheimer's Symptoms Before They Begin? Inside the PrevenTRON Trial

2

Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection

3

Next-Generation CNS Drug Delivery: Brainshuttle Technology and Clinical Implications in Alzheimer Disease

4

Multidisciplinary Coordination in TK2d Diagnosis and Management

5

Advancing MOGAD Care

6

Navigating Stem Cell Therapy Conversations in MS

7

Cognitive Screening in MS: Practical Strategies and Modern Approaches

8

Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols

9

Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role

10

Understanding Variability in Myasthenia Gravis

11

Examining the Global Genetic Prevalence of TK2d

12

Next-Generation MS Care: The Promise of Cell-Based Therapeutics

13

Advances in Cell-Based Therapy for MS

14

Proactive Pregnancy Planning and Reproductive Care in MS

15

Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis

16

Updates in MS Care: Key Topics at AAN 2026

17

Advancing Pediatric MS Care: Insights from AAN 2026

18

Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care

19

Understanding Accelerated Biological Aging in Pediatric MS

20

Advancing MS Care with Multimodal Aging Signatures and Proteomic Biomarkers

21

Parkinson’s Research in Focus: Translating Science Into Clinical Progress

22

Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care

23

Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant

24

Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS

25

Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics

26

The Future of MS Management: Novel Agents and Clinical Approaches

27

Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis

28

Modern MS Care: Navigating Treatment Options for Better Patient Outcomes

29

Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy

30

Understanding MS: Managing Hidden and Overlooked Symptoms

31

Advancing MS Care: Evolving Treatments and High-Efficacy Approaches

32

Recognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care

33

Tuning the Brain: Personalized Anxiety Relief with Neurofeedback-Driven Headphones

34

Transforming Clinician Wellness: EEG Headphones Helping with Burnout

35

Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools

36

How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life

37

Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause

38

Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery

39

Transitioning to Adult Care in DMD: Strategies for Long-Term Support

40

Supporting Adults With DMD: A Guide to Acute and Long-Term Planning

41

Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations

42

Harnessing Neuroplasticity: Timing and Intensity in Post-Stroke Aphasia Intervention

43

Inflammatory Gateways: Exploring the Role of the Choroid Plexus in Post-TBI Care

44

mIDH Gliomas Explained: Characteristics and Management Strategies

45

Climate Change in the Clinic: Examining Neurological Impacts

46

From Diagnosis to Treatment: Challenges in Glioblastoma Care

47

Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data

48

Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination

49

Safety Outcomes in MS Clinical Trials: Examining Comorbidities and Adverse Events

50

MS and the Ketogenic Diet: Potential Impacts on Inflammation and Relapse

51

Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD

52

Emerging Technologies in MS: Neuromodulation and Myelin Regeneration

53

MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies

54

Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life

55

Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions

56

Navigating Myasthenia Gravis in Adolescents and Young Adults

57

Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids

58

The Evolving gMG Treatment Landscape

59

FcRn Inhibitors: A Potential New Targeted Therapy Option

60

Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic

61

Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients

62

Continuum of Care: Managing DMD in Pediatric and Adult Patients

63

Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety

64

Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus

65

The Impact of a cholesterol-lowering medication on Alzheimer’s Disease

66

How DDL-920 Could Help Restore Cognitive Function in Alzheimer’s Patients

67

Evaluating Endocrine Complications in DMD Patients: Findings from a Survey

68

Key Highlights from ECTRIMS 2024

69

The Impact of ECTRIMS Over 40 Years

70

Updates to the Diagnostic Criteria for MS Patients

71

The Silent Struggle: Understanding ADHD's Impact on Girls and Women

72

Addressing ADHD in Women: A Guide to Diagnosis and Treatment

73

Reviewing the Treatment Landscape for Duchenne Muscular Dystrophy

74

ADHD in Older Adults: Key Diagnostic and Treatment Strategies

75

Managing and Treating ADHD from Childhood to Adulthood

76

Exploring the Role of Nutrition in Managing Neurological Disorders

77

Understanding Pain Management in Children with Neurological Disorders

78

Differentiating the Diagnosis Between ADHD and Sleep Disorders

79

Helping Adult Patients Find the Right Treatment for ADHD Symptoms

80

Climate Change and Neurological Infections: The Effects Over Time

81

Maternal Stroke: Causes, Risks, and Care in Pregnancy and Postpartum

82

Managing Internal Medicine Issues in Hospitalized Neurological Patients

83

Recognizing and Addressing Medical Gaslighting in Healthcare

84

Exploring the Clinical Treatments of Schizophrenia

85

The Role of Occupational Therapy in Schizophrenia Management

86

Investigating the Prevalence of Comorbidities in MS Clinical Trials

87

Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment

88

Assessing Disability in MS Patients with the SNRS and CombiWISE Tools

89

Understanding the Cellular Basis for Altered Cognition in Schizophrenia

90

Practices for Preventing Polypharmacy in Multiple Sclerosis

91

From Assessment to Management: Tackling Catatonia in Schizophrenic Patients

92

How Alzheimer's and Lewy Body Pathology Impact CAA Risk Factors

93

Exploring the Latest in MS Cognitive Rehabilitation Strategies

94

Visionary Insights: Assessing MS-Related Retinal Changes with Adaptive Optics

95

Family Planning Clinical Considerations for Patients with Multiple Sclerosis

96

Unmet Needs in Rehabilitation Research for Multiple Sclerosis

97

MS Research: Using Epigenetic Clocks and Biomarkers to Assess Biological Aging

98

Telehealth in MS Care: Addressing the Potential for Improvement and Concerns

99

Toxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease

100

Schizophrenia Diagnosis: The Importance of a Collaborative Approach

101

Examining the Role of Toxic Tau Proteins in Alzheimer's Disease

102

New Study Shows EBV-Specific T-Cells Contribute to MS Development

103

A Successful and Safe Stem Cell Therapy for Progressive MS

104

PBA Treatment May Reverse Signs of Alzheimer’s Disease

105

Alzheimer’s Research: Opening the Blood-Brain Barrier with Aducanumab and Focused Ultrasound

106

First Episode Psychosis: Improving Patient Outcomes Through Early Intervention

107

Investigating the Clinical Utility of the Multiple Sclerosis Disease Activity Test

108

Adverse Childhood and Lifespan Stressors Take a Toll on MS Disease Severity

109

MS in Black and Hispanic Patients: Examining Prevalence and Disease Characteristics

110

Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS

111

MS in Children: Exploring Biomarker Research Advancements

112

Discussing Disparities in MS Care for Underrepresented Populations

113

Discussing the Latest in MS Treatment and Disease-Modifying Therapies

114

Highlights from the 2023 Psych Congress

115

Diagnosing Suspected MS: A Review of the Updated Guidelines

116

Studying the Safety of Discontinuing DMTs in MS Older Adults

117

Uncovering Disease Progression in Multiple Sclerosis

118

Examining the Correlation Between HIV & Neurocognitive Disorders

119

Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations

120

NIH Study Identifies Cause for Long COVID Neurological Symptoms

121

Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting

122

Combating Controversies in BPSD Care

123

The Cell Death Pathway: Leveraging Glioblastoma Treatments

124

What to Expect at the 2023 APA Annual Meeting

125

Treating BPSD with Cannabinoids: What We Currently Know

126

Seizures & Epilepsy: How Cell Phone Videos Could be an Effective Tool

127

A Look at Lecanemab: The Latest Breakthrough in Alzheimer’s Treatment

128

First Responders with PTSD: Exploring the Neurological Underpinnings

129

Childhood-Onset Epilepsy: A Look into the Effects of Aging

130

The Impact of Individual Autonomic Domains in Parkinson’s Disease

131

Treating Trauma with EMDR Therapy

132

Diving into the Genetic Pathway: A Look at the STING Pathway & Brain Cancer

133

Exploring New Research on Melanoma Brain Metastases

134

Discovering Face Blindness: An Expert’s Perspective on Prosopagnosia

135

Advances in Temporal Lobe Epilepsy Research

136

AI in Neurology: What Tools Are Emerging?

137

Clinical Considerations for the Treatment of Schizophrenia

138

Investigating the Link Between Hypertension Medications & Dementia

139

B-Cell Therapy: When Is It Right for Our MS Patients?

140

Alzheimer’s Disease: What’s The Latest Research?

141

Diving into the Debate Surrounding Aducanumab for Alzheimer’s

142

Keys to Closing the Gender Gap in Stroke Trials

143

Diagnosing Mental Illness with the Perspectives Approach

144

Reducing Relapse for Schizophrenia Patients: A Look at LAI Antipsychotics

145

Tracking Transition Readiness & Quality of Life Among Pediatric MS Patients

146

A Recap of the Rehabilitation Track at CMSC

147

The Importance of Collaboration in MS Care: Takeaways from CMSC

148

What to Know About Post-COVID-19 Neurological Syndrome

149

Could T Cells Lead to New MS Treatments?

150

Caring for Treatment-Resistant Schizophrenia: Is DBS the Answer?

151

What to Consider When Treating Transgender Patients with Epilepsy

152

Women & Mental Health: Taking a Targeted Treatment Approach

153

Uncovering Unknowns in TBI: An Exploration of Manifestations in Women

154

Understanding the Brain: An Exploration of an Extraordinary Organ

155

Real-Time Dialogue with Dreamers: An Exploration of Communication During REM Sleep

156

The Dangers of a Broken Heart: Collaborating on Cardiomyopathy

157

Investigating Impulses: A Look at Deep Brain Stimulation

158

Deep Brain Stimulation in the OR: What Neurologists & Patients Can Expect

159

Exploring the Evolving Landscape in Managing Multiple Sclerosis

160

Shedding Light on the Brain After COVID-19: Assessing the Spectrum of Neurological Risk

161

Seeking Out Symptoms of Broken Heart Syndrome

162

Expanding on the Neurologic Effects of COVID-19

163

The Future of Restoring Functionality in Stroke Survivors

164

Refocusing Our Efforts on Advancing Technology to Help Stroke Survivors

165

Pressing Play: Do Video Games Have a Role in Healthcare?

166

How Does COVID-19 Affect the Mind?

167

Investigating the Variants of the COVID-19 Virus

168

Evaluating the Evolving Field of Fetal Neurology

169

Spotlight on Meningiomas: Risks and Clinical Manifestations

170

A New Game Plan for Treating Concussions

171

Treating Diabetic Nerve Pain: Guidelines from the American Academy of Neurology

172

How Smart Phones Are Improving Neurologic Care

173

The Doctor Will See All of You Now: New Approaches to Treating Parkinson's Disease

174

How to Help Patients Cope With Loss of Taste and Smell

175

Emerging New Therapies for Multiple Sclerosis Patients

176

Updated Guidelines for Brain Death and the Impact on Organ Donation

177

Solving the Mystery of Restless Leg Syndrome

178

Strategies to Improve Critical Care of a Gunshot Wound to the Head

179

Repurposing Botulinum Toxin as Treatment for Chronic Migraines

180

Alzheimer's and Driving: When It's Time to Take the Keys

181

Dispatches From the Haiti Earthquake Relief

182

Guillain-Barre Syndrome and the H1N1 Vaccine in Context

183

Expanded Window of Time for Treating Stroke

184

Novel Thinking in Alzheimer’s Screening and Treatment

185

The Dizzy Patient: Recommended Therapies for Vertigo

186

Sudden Death in Sports

187

Diagnosis and Treatment of Multiple Sclerosis

188

Chronic Neuropathic Pain and Peripheral Neuropathy

189

Research Innovations in Pediatric Migraines

190

Vascular Risks of Migraines

191

Epilepsy Drug Substitution and Epilepsy Drugs in Pregnancy